Involvement of Nrf2 signaling pathway in the neuroprotective activity of natural kaurane diterpenes

Neuroscience

Volumn 231, Issue , 2013, Pages 400-412

  Gonzalez Burgos E ^a   Carretero, M E ^a   Gomez Serranillos M P ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Antioxidant; Astrocytes; Kaurane diterpenes; Neuroprotection; Nrf2 pathway; Oxidative stress

Indexed keywords

CATALASE; FOLIOL; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HEME OXYGENASE 1; LINEAROL; NEUROPROTECTIVE AGENT; REACTIVE OXYGEN METABOLITE; SIDOL; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2; TROLOX C; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; LIPID PEROXIDATION; NEUROPROTECTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

APOPTOSIS; ASTROCYTES; CELL LINE, TUMOR; CELL SURVIVAL; DITERPENES, KAURANE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HUMANS; HYDROGEN PEROXIDE; LIPID PEROXIDATION; NEUROPROTECTIVE AGENTS; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84872848421     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.10.018     Document Type: Article

References (53)

1. Aebi H. Catalase in vitro. Methods Enzymol 1984, 105:121-125.
2. Avery S.V. Molecular targets of oxidative stress. Biochem J 2011, 434:201-210.
3. Barja de Quiroga G., Perez-Campo R., López-Torres M. Anti-oxidant defences and peroxidation in liver and brain of aged rats. Biochem J 1990, 272:247-250.
4. Barnham K.J., Masters C.L., Bush A.I. Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 2004, 3:205-214.
5. Castrillo A., de las Heras B., Hortelano S., Rodríguez B., Villar A., Boscá L. Inhibition of the nuclear factor κB (NF-κB) pathway by tetracyclic kaurene diterpenes in macrophages. J Biol Chem 2001, 276:15854-15860.
6. Choi S.Y., Lee K.J., Kim H.G., Han E.H., Chung Y.C., Sung N.J., Jeong H.G. Protective effect of the coffee diterpenes kahweol and cafestol on tert-butyl hydroperoxide-induced oxidative hepatotoxicity. Bull Korean Chem Soc 2006, 27:1386-1392.
7. Davalos A., Gomez-Cordoves C., Bartolome B. Extending applicability of the Oxygen Radical Absorbance Capacity (ORAC-Fluorescein) assay. J Agric Food Chem 2004, 52:48-54.
8. de las Heras B., Hortelano S., Girón N., Bermejo P., Rodríguez B., Boscá L. Kaurane diterpenes protect against apoptosis and inhibition of phagocytosis in activated macrophages. Br J Pharmacol 2007, 152:249-255.
9. de Quesada T.G., Rodriguez B., Valverde S., Huneck S. Six new diterpenes from Sideritis leucantha Cav. and S. linearifolia Lam. Tetrahedron Lett 1972, 22:2187-2190.
10. Du Y., Villeneuve N.F., Wang X.J., Sun Z., Chen W., Li J., Lou H., Wong P.K., Zhang D.D. Oridonin confers protection against arsenic-induced toxicity through activation of the Nrf2-mediated defensive response. Environ Health Perspect 2008, 116:1154-1161.
11. Dumont A., Hehner S.P., Hofmann T.G., Ueffing M., Dröge W., Schmitz M.L. Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-kappaB. Oncogene 1999, 18:747-757.
12. Ehrnhoefer D.E., Wong B.K., Hayden M.R. Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development. Nat Rev Drug Discov 2011, 10:853-867.
13. Garcia P.A., Braga De Oliveira A., Batista R. Occurrence, biological activities and synthesis of kaurane diterpenes and their glycosides. Molecules 2007, 12:455-483.
14. González-Burgos E., Carretero M.E., Gómez-Serranillos M.P. Sideritis spp.: uses, chemical composition and pharmacological activities-A review. J Ethnopharmacol 2011, 135:209-225.
15. Gómez-Serranillos P., Carretero E., Slowing K., Palomino O.M., Villarrubia A.I., Villar A. HPLC Quantitative analysis of diterpenoids in Sideritis (Labiatae) species. Phytother Res 1998, 72:S101-S103.
16. Gómez-Serranillos M.P., El-Naggar T., Villar A.M., Carretero M.E. Analysis and retention behaviour in high-performance liquid chromatography of terpenic plant constituents (Sideritis spp.) with pharmacological interest. J Chromatogr B 2004, 812:379-383.
17. Gómez-Serranillos P., Palomino O.M., Villarrubia A.T., Cases M.A., Carretero E., Villar A. Analysis of diterpenoids from Sideritis species by reversed-phase high-performance liquid chromatography. J Chromatogr A 1997, 778:421-425.
18. Grotto D., Santa Maria L.D., Boeira S., Valentini J., Charão M.F., Moro A.M., Nascimiento P.C., Pomblum V.J., Halliwell B., Clement M.V., Long L.H. Hydrogen peroxide in the human body. FEBS Lett 2000, 486:10-13.
19. Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem 1992, 59:1609-1623.
20. Halliwell B. Oxidative stress in cell culture: an under-appreciated problem?. FEBS Lett 2003, 540:3-6.
21. Han D., Sen C.K., Roy S., Kobayashi M.S., Tritschler H.J., Packer L. Protection against glutamate-induced cytotoxicity in C6 glial cells by thiol antioxidants. Am J Physiol 1997, 273:R1771-R1778.
22. Hayashi M., Miyata R., Tanuma N. Oxidative stress in developmental brain disorders. Adv Exp Med Biol 2012, 724:278-290.
23. Higgins L.G., Cavin C., Itoh K., Yamamoto M., Hayes J.D. Induction of cancer chemopreventive enzymes by coffee is mediated by transcription factor Nrf2. Evidence that the coffee-specific diterpenes cafestol and kahweol confer protection against acrolein. Toxicol Appl Pharmacol 2007, 226:328-337.
24. Hissin P., Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976, 74:214-226.
25. Holmquist L., Stuchbury G., Steele M., Münch G. Hydrogen peroxide is a true first messenger. J Neural Transm Suppl 2007, 72:39-41.
26. Hwang Y.P., Jeong H.G. The coffee diterpene kahweol induces heme oxygenase-1 via the PI3K and p38/Nrf2 pathway to protect human dopaminergic neurons from 6-hydroxydopamine-derived oxidative stress. FEBS Lett 2008, 582:2655-2662.
27. Jazwa A., Cuadrado A. Targeting heme oxygenase-1 for neuroprotection and neuroinflammation in neurodegenerative diseases. Curr Drug Targets 2010, 11:1517-1531.
28. Katsuno M., Tanaka F., Sobue G. Perspectives on molecular targeted therapies and clinical trials for neurodegenerative diseases. J Neurol Neurosurg Psychiatry 2012, 83:329-335.
29. Koh J.Y., Choi D.W. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Methods 1987, 20:83-90.
30. LeBel C.P., Ischiropoulos H., Bondy S.C. Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 1992, 5:227-231.
31. Lee J.M., Johnson J.A. An important role of Nrf2-ARE pathway in the cellular defense mechanism. J Biochem Mol Biol 2004, 37:139-143.
32. Lee K.J., Choi J.H., Jeong H.G. Hepatoprotective and antioxidant effects of the coffee diterpenes kahweol and cafestol on carbon tetrachloride-induced liver damage in mice. Food Chem Toxicol 2007, 45:2118-2125.
33. Lyu J.H., Lee G.S., Kim K.H., Kim H.W., Cho S.I., Jeong S.I., Kim H.J., Ju Y.S., Kim H.K., Sadikot R.T., Christman J.W., Oh S.R., Lee H.K., Ahn K.S., Joo M. Ent-kaur-16-en-19-oic acid, isolated from the roots of Aralia continentalis, induces activation of Nrf2. J Ethnopharmacol 2011, 137:1442-1449.
34. Marklund S., Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974, 47:469-474.
35. Martin D., Rojo A.I., Salinas M., Diaz R., Gallardo G., Alam J., De Galarreta C.M., Cuadrado A. Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol. J Biol Chem 2004, 279:8919-8929.
36. Melo A., Monteiro L., Lima R.M., Oliveira D.M., Cerqueira M.D., El-Bachá R.S. Oxidative stress in neurodegenerative diseases: mechanisms and therapeutic perspectives. Oxid Med Cell Longev 2011, 2011:467180.
37. Mosmann T. Rapid colorimetric assay for celular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.
38. Motterlini R., Foresti R., Intaglietta M., Winslow R.M. NO-mediated activation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium. Am J Physiol 1996, 270:H107-H114.
39. Ndhlala A.R., Moyo M., Van Staden J. Natural antioxidants: fascinating or mythical biomolecules?. Molecules 2010, 15:6905-6930.
40. Paglia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967, 70:158-169.
41. Pajares M.A., Duran C., Corrales F., Pliego M., Mato J. Modulation of a rat liver S-adenosylmethionine synthetase activity by glutathione. J Biol Chem 1992, 267:17598-17605.
42. Pavlica S., Gebhardt R. Protective effects of flavonoids and two metabolites against oxidative stress in neuronal PC12 cells. Life Sci 2010, 86:79-86.
43. Prior R.L., Cao G. In vivo total antioxidant capacity: comparison of different analytical methods. Free Rad Biol Med 1999, 27:1173-1181.
44. Reed T.T. Lipid peroxidation and neurodegenerative disease. Free Radic Biol Med 2011, 51:1302-1319.
45. Rodríguez-Linde M.E., Díaz R.M., García-Granados A., Quevedo-Sarmiento J., Moreno E., Onorato M.R. Antimicrobial activity of natural and semisynthetic diterpenoids from Sideritis spp. Microbios 1994, 77:7-13.
46. Stone J.R., Yang S. Hydrogen peroxide: a signaling messenger. Antioxid Redox Signal 2006, 8:243-270.
47. Tabner B.J., Turnbull S., El-Agnaf O., Allsop D. Production of reactive oxygen species from aggregating proteins implicated in Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases. Curr Top Med Chem 2001, 1:507-517.
48. Tabner B.J., Turnbull S., El-Agnaf O.M., Allsop D. Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease. Free Radic Biol Med 2002, 32:1076-1083.
49. Takahashi K., Kunishiro K., Kasai M., Miike T., Kurahashi K., Shirahase H. Relationships between lipophilicity and biological activities in a series of indoline-based anti-oxidative acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors. Arzneimittelforschung 2008, 58:666-672.
50. Townsend D.M., Tew K.D., Tapiero H. The importance of glutathione in human disease. Biomed Pharmacother 2003, 57:145-155.
51. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007, 9:44-84.
52. Veal E., Day A. Hydrogen peroxide as a signaling molecule. Antioxid Redox Signal 2011, 15:147-151.
53. Xu J., Guo P., Liu C., Sun Z., Gui L., Guo Y., Yamakuni T., Ohizumi Y. Neuroprotective kaurane diterpenes from Fritillaria ebeiensis. Biosci Biotechnol Biochem 2011, 75:1386-1388.